>
New image sheds light on China's secret spaceplane
France to Impose 'Riot Tax' on Insurance to Pay for Damage of Islamo-Leftist Unrest
A3Podcast Special Report 30 Oct 26 - Increased Risk
Microreactor Gets DOE Approval for Full Power Testing, Previously Contracts with Army...
Microreactor Gets DOE Approval for Full Power Testing, Previously Contracts with Army...
Ford Fathom: Everything We Know About The Sub-$30,000 Affordable EV Truck
Love it or loathe it, AI is birthing a golden age of science
SpaceX has no competition -- Saurav Shroff, Starpath
Living computers forge a 'hive mind' and work together to outsmart AI
The Faraday duffle bag: A digital lifeline in a surveillance-saturated world
Delivery Robots Accused Of Scanning Customers' Faces, Sharing Biometric Data
Brace Yourselves: Serious Trouble Brewing In The Data Center Industry
FDA-Approval for Drill-Free Cavity Care May Be Imminent After Great Phase 3 Treatment Trial
California Startup Says It Has Injected AI-Designed Virus Into Humans For First Time

Late-stage lung cancer. No cure. Three months to live.
It was the 2016 diagnosis Joe Tippens said he wasn't willing to accept. The Edmond, Oklahoma man was determined to live at least long enough to meet his first grandson, due in a few months.
Tippens immediately contacted MD Anderson and was on a flight to Houston that night.
He said chemo and radiation at MDA shrunk the large tumor in his lung. But after he finished treatment, a PET scan revealed it was too late.
"The cancer had spread to my neck, my Right Lung, my stomach, my liver, my bladder, my pancreas and my tail bone. Dozens of tumors," Tippens wrote in his blog.
Two days after the PET scan, Tippens said a veterinarian friend told him about a dog dewormer called fenbendazole that some people believe cured their cancer. It's branded as Panacur C and can be ordered online.
Tippens did some research and learned the drug is considered safe for humans, with no serious side effects.
"I had just been told I've got no hope and 3 months to live, so it wasn't a hard decision for me to take the leap," Tippens wrote.
He said he took fenbendazole, along with a vitamin and supplement regimen, while also taking part in an unrelated trial at MD Anderson. Doctors said the trial wouldn't save his life, but it might extend it.
Tippens didn't tell his oncologist about the fenbendazole because he was afraid they would kick him out of the trial.